T cell exhaustion in cancer: from functional decline to adaptive immune regulation
4 affiliations
- 1College of First Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China
- 2Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, China
- 3College of Traditional Chinese Medicine, Shandong Second Medical University, Weifang, China
- 4Department of Oncology, Weifang Traditional Chinese Hospital, Weifang, China
Abstract
T cell exhaustion has traditionally been defined as a state of progressive functional impairment and specific epigenetic remodeling induced by chronic antigen stimulation. However, emerging multidisciplinary evidence indicates that exhaustion is not merely a terminal stage of functional failure; rather, it represents an evolutionarily conserved adaptive program designed to balance long-term immune surveillance with the limitation of excessive pathological damage. This review focuses on the positive regulatory roles of T cell exhaustion within the tumor microenvironment. It elucidates how the exhausted state avoids lethal inflammation by restraining excessive activation while preserving a durable progenitor pool, thereby ultimately establishing a homeostatic balance between sustained tumor control and host survival. Overall, a comprehensive understanding of the evolutionary principles underlying this adaptive program provides important guidance for the design of precision immunotherapies that balance efficacy and safety. Strategically targeting and harnessing these protective features may greatly optimize the clinical benefits of solid tumor treatment and guide the development of next-generation innovative immunotherapies.
Graphical Abstract:
Related
- FOXM1 as a candidate dosage rheostat and state selector in breast cancer: linking multilevel regulation to adaptive plasticity and therapy resistance
- No decline in functional status or cognitive function during the first year after treatment initiation for early-stage breast cancer in women aged 75 years and older: a prospective observational matched cohort study
- 166 CARD8- and SRCAP-deficient CAR T-cells promote durable responses and limit functional exhaustion
- WITHDRAWN: Connecting Baseline Immune Exhaustion in Hot Tumors to Oral Cancer Recurrence and Nodal Metastasis
- 1143 Obesity promotes interferon-driven regulatory T-cell activation and CD8 T-cell exhaustion in triple-negative breast cancer
BibTeX
@article{wang2026cell,
title = {{T cell exhaustion in cancer: from functional decline to adaptive immune regulation}},
author = {Yanyang Wang and Yang Yu and Jing Zhuang and Ruijuan Liu and Changgang Sun},
journal = {Molecular Cancer},
year = {2026},
month = aug,
doi = {10.1186/s12943-026-02767-7},
url = {https://doi.org/10.1186/s12943-026-02767-7},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - T cell exhaustion in cancer: from functional decline to adaptive immune regulation
AU - Yanyang Wang
AU - Yang Yu
AU - Jing Zhuang
AU - Ruijuan Liu
AU - Changgang Sun
PY - 2026
DA - 2026/08/06
JO - Molecular Cancer
DO - 10.1186/s12943-026-02767-7
UR - https://doi.org/10.1186/s12943-026-02767-7
AB - T cell exhaustion has traditionally been defined as a state of progressive functional impairment and specific epigenetic remodeling induced by chronic antigen stimulation. However, emerging multidisciplinary evidence indicates that exhaustion is not merely a terminal stage of functional failure; rather, it represents an evolutionarily conserved adaptive program designed to balance long-term immune surveillance with the limitation of excessive pathological damage. This review focuses on the positive regulatory roles of T cell exhaustion within the tumor microenvironment. It elucidates how the exhausted state avoids lethal inflammation by restraining excessive activation while preserving a durable progenitor pool, thereby ultimately establishing a homeostatic balance between sustained tumor control and host survival. Overall, a comprehensive understanding of the evolutionary principles underlying this adaptive program provides important guidance for the design of precision immunotherapies that balance efficacy and safety. Strategically targeting and harnessing these protective features may greatly optimize the clinical benefits of solid tumor treatment and guide the development of next-generation innovative immunotherapies. Graphical Abstract:
SN - 1476-4598
ER -